Tessera Defense & Homeland Security, Inc. (HLSQ)
0.2605
-0.01
(-4.05%)
USD |
NYAM |
Oct 23, 16:00
0.2617
0.00 (0.00%)
After-Hours: 20:00
Tessera Defense & Homeland Security Enterprise Value : 16.40M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 16.40M |
| October 22, 2026 | 16.41M |
| October 21, 2026 | 16.37M |
| October 20, 2026 | 16.37M |
| October 19, 2026 | 16.35M |
| October 16, 2026 | 16.35M |
| October 15, 2026 | 16.39M |
| October 14, 2026 | 16.37M |
| October 13, 2026 | 16.40M |
| October 12, 2026 | 16.42M |
| October 09, 2026 | 16.43M |
| October 08, 2026 | 16.44M |
| October 07, 2026 | 16.46M |
| October 06, 2026 | 16.46M |
| October 05, 2026 | 16.59M |
| October 02, 2026 | 16.53M |
| October 01, 2026 | 16.56M |
| September 30, 2026 | 16.58M |
| September 29, 2026 | 16.62M |
| September 28, 2026 | 16.67M |
| September 25, 2026 | 16.74M |
| September 24, 2026 | 16.74M |
| September 23, 2026 | 16.76M |
| September 22, 2026 | 16.91M |
| September 21, 2026 | 16.98M |
| Date | Value |
|---|---|
| September 18, 2026 | 16.96M |
| September 17, 2026 | 16.93M |
| September 16, 2026 | 16.98M |
| September 15, 2026 | 17.29M |
| September 14, 2026 | 17.42M |
| September 11, 2026 | 17.67M |
| September 10, 2026 | 18.40M |
| September 09, 2026 | 18.11M |
| September 08, 2026 | 18.02M |
| September 04, 2026 | 17.93M |
| September 03, 2026 | 17.86M |
| September 02, 2026 | 17.87M |
| September 01, 2026 | 17.87M |
| August 31, 2026 | 17.80M |
| August 28, 2026 | 17.81M |
| August 27, 2026 | 17.74M |
| August 26, 2026 | 17.72M |
| August 25, 2026 | 17.77M |
| August 24, 2026 | 17.76M |
| August 21, 2026 | 17.80M |
| August 20, 2026 | 17.83M |
| August 19, 2026 | 17.79M |
| August 18, 2026 | 17.78M |
| August 17, 2026 | 17.89M |
| August 14, 2026 | 17.92M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agenus, Inc. | 534.42M |
| Amgen, Inc. | 280.78B |
| Anika Therapeutics, Inc. | 273.50M |
| BioCryst Pharmaceuticals, Inc. | 2.436B |
| Imunon, Inc. | 6.743M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.846M |
| Revenue (Quarterly) | 0.332M |
| Total Expenses (Quarterly) | 4.104M |
| EPS Diluted (Quarterly) | -3.658 |
| Gross Profit Margin (Quarterly) | 29.22% |
| Profit Margin (Quarterly) | -1.16K% |
| Earnings Yield | -83.16K% |
| Normalized Earnings Yield | -52422.80 |